These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 34765383)

  • 1. Evaluating the Use of Hydroxychloroquine in Treating Patients With Rheumatoid Arthritis.
    Nazir AM; Koganti B; Gupta K; Memon MS; Aslam Zahid MB; Shantha Kumar V; Tappiti M; Mostafa JA
    Cureus; 2021 Nov; 13(11):e19308. PubMed ID: 34765383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
    Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
    Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid use in rheumatoid arthritis patients and the onset of pneumonia: a systematic review and meta-analysis.
    Elsouri KN; Arboleda V; Basbous L; Heiser S; Collins DP; Ragusa P; Baxter C; Cabrera D; Akhand T; Stermer E; Sharma K; Seguro C; Hardigan P; Kesselman M; Beckler MD
    J Osteopath Med; 2023 Apr; 123(4):179-186. PubMed ID: 36691851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis.
    Curtis JR; Palmer JL; Reed GW; Greenberg J; Pappas DA; Harrold LR; Kremer JM
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1114-1124. PubMed ID: 32374918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis.
    Cordova Sanchez A; Khokhar F; Olonoff DA; Carhart RL
    Cardiovasc Drugs Ther; 2024 Apr; 38(2):297-304. PubMed ID: 36197529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Rempenault C; Combe B; Barnetche T; Gaujoux-Viala C; Lukas C; Morel J; Hua C
    Ann Rheum Dis; 2018 Jan; 77(1):98-103. PubMed ID: 28970215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review.
    Rempenault C; Combe B; Barnetche T; Gaujoux-Viala C; Lukas C; Morel J; Hua C
    Arthritis Care Res (Hoboken); 2020 Jan; 72(1):36-40. PubMed ID: 30629341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
    Karlsson JA; Neovius M; Nilsson JÅ; Petersson IF; Bratt J; van Vollenhoven RF; Ernestam S; Geborek P
    Ann Rheum Dis; 2013 Dec; 72(12):1927-33. PubMed ID: 23196701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis.
    Cummins L; Katikireddi VS; Shankaranarayana S; Su KY; Duggan E; Videm V; Pahau H; Thomas R
    Intern Med J; 2015 Dec; 45(12):1266-73. PubMed ID: 26384029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
    van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE
    Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Hydroxychloroquine Is Associated With Improved Lipid Profile in Rheumatoid Arthritis Patients.
    Restrepo JF; Del Rincon I; Molina E; Battafarano DF; Escalante A
    J Clin Rheumatol; 2017 Apr; 23(3):144-148. PubMed ID: 28277344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine and Chloroquine-Induced Cardiac Arrhythmias and Sudden Cardiac Death in Patients with Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis.
    Nikolic RPA; Virk MK; Buhler KA; Costenbader KH; Choi MY; Weber B
    J Cardiovasc Pharmacol; 2024 May; ():. PubMed ID: 38922589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of hydroxychloroquine as maintenance therapy for rheumatoid arthritis after combination therapy with methotrexate and hydroxychloroquine.
    Clegg DO; Dietz F; Duffy J; Willkens RF; Hurd E; Germain BF; Wall B; Wallace DJ; Bell CL; Sleckman J
    J Rheumatol; 1997 Oct; 24(10):1896-902. PubMed ID: 9330929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
    O'Dell JR; Leff R; Paulsen G; Haire C; Mallek J; Eckhoff PJ; Fernandez A; Blakely K; Wees S; Stoner J; Hadley S; Felt J; Palmer W; Waytz P; Churchill M; Klassen L; Moore G
    Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of tumor necrosis factor α in rheumatoid arthritis.
    Kulp W; Corzillus M; Greiner W; Pientka L; Siebert U; von der Schulenburg JM; Wasem J
    GMS Health Technol Assess; 2005 Dec; 1():Doc12. PubMed ID: 21289933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine use is associated with reduced mortality risk in older adults with rheumatoid arthritis.
    Iyer P; Gao Y; Jalal D; Girotra S; Singh N; Vaughan-Sarrazin M
    Clin Rheumatol; 2024 Jan; 43(1):87-94. PubMed ID: 37498463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
    Gubar' EE; Bochkova AG; Bunchuk NV
    Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications.
    Kerr G; Aujero M; Richards J; Sayles H; Davis L; Cannon G; Caplan L; Michaud K; Mikuls T
    Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1619-26. PubMed ID: 24692402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of cyclosporine A with methotrexate or hydroxychloroquine in refractory rheumatoid arthritis.
    Salaffi F; Carotti M; Cervini C
    Scand J Rheumatol; 1996; 25(1):16-23. PubMed ID: 8774550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal microvascular density analysis in patients with rheumatoid arthritis treated with hydroxychloroquine.
    Esser EL; Zimmermann JA; Storp JJ; Eter N; Mihailovic N
    Graefes Arch Clin Exp Ophthalmol; 2023 May; 261(5):1433-1442. PubMed ID: 36580078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.